Osteoimmunology: Wnt antagonists: for better or worse?
Where this comes from
- Record sourced from PubMed, PMID 19648940.
- Also identified by DOI 10.1038/nrrheum.2009.144.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Molecules involved in developmental signaling pathways have emerged as therapeutic targets for various rheumatic diseases. New research sheds light on the consequences of interfering with these processes.
Medical subject headings
- Antirheumatic Agents
- Signal Transduction
- Spondylarthropathies
- Wnt Proteins